Axillary dissection over the years: Where to from here?

World Journal of Surgery

Volumn 25, Issue 6, 2001, Pages 761-766

  Keshtgar, M R S ^a   Baum, M ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AXILLARY LYMPH NODE; BREAST CANCER; CANCER STAGING; CANCER SURGERY; HUMAN; LYMPH NODE DISSECTION; PROGNOSIS; REVIEW; SENTINEL LYMPH NODE BIOPSY;

AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY;

EID: 0034995720     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-001-0002-y     Document Type: Review

References (71)

1. Axillary lymph node dissection for T1a breast carcinoma
2. Impact of axillary lymph node dissection on the therapy of breast cancer patients
3. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer
4. The psychological morbidity of breast cancer-related arm swelling
5. On the influence of inadequate operations on the therapy of cancer
6. Zur behandlung brestkrebsen
7. The results of operations for the cure of the cancer of breast performed at the Johns Hopkins Hospital from June 1889 to January 1894
8. Carcinoma of the breast. II. Criteria of operability
9. Prognosis of carcinoma of the breast in relation to the type of operation performed
10. The significance of regional node metastases in breast cancer
11. The surgical dilemma in the primary therapy of invasive breast cancer: A critical appraisal
12. Ten year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation
13. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer
14. Effects of radiotherapy and surgery in early breast cancer: An overview of randomized trials
15. Comparing radical mastectomy with quadrantectomy, axillary dissection and radiotherapy in patients with small cancers of breast
16. Axillary nodes in breast cancer
17. Clinical evaluation of axillary lymph nodes compared to surgical and pathological findings
18. Lymphoscintigraphic evaluation of 250 patients with malignant melanoma
19. Role of computed tomography in staging of breast cancer
20. Ultrasound detection of axillary lymph node metastases in breast cancer
21. Technetium-99m-sestamibi uptake in breast tumour and associated lymph nodes
22. Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer
23. Primary and metastatic breast carcinoma: Initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose
24. Primary management of carcinoma of breast
25. Assessment of axillary node status
26. Factors influencing local recurrence after excision and radiotherapy for primary breast cancer
27. Simple mastectomy and axillary node sampling in the management of primary breast cancer
28. The efficacy of lower axillary sampling in obtaining lymph node status in breast cancer; a controlled randomised trial
29. The inadequacy of axillary sampling in breast cancer
30. Management and survival of female breast cancer: Results of a national survey by the American College of Surgeons
31. Relation of tumour size, lymph node status and survival in 24,740 breast cancer cases
32. The prognostic significance of lymph node metastases after pre-operative chemotherapy for locally advanced breast cancer
33. Extent of metastatic axillary involvement in 1446 cases of breast cancer
34. Breast cancer, risk of axillary recurrence in node negative patients following partial dissection of the axilla
35. A detailed update at the tenth year: CRC working party
36. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer
37. Postoperative radiotherapy in high risk premenopausal women with breast cancer who receive adjuvant chemotherapy: Danish Breast Cancer Cooperative Group 82b trial
38. Radiation therapy and survival in breast cancer patients with a 10 or more positive axillary lymph nodes treated with mastectomy
39. Is breast conserving surgery with radiation superior to mastectomy in a selected patients?
40. The axilla; not a no-go zone
41. Patients with early breast cancer benefit from axillary treatment
42. Survival following locoregional recurrence after breast conservation therapy for cancer
43. Sentinel-lymph-node biopsy for breast cancer: Not yet the standard of care
44. Radiation therapy with or without primary limited surgery for operable breast cancer
45. Conservative treatment of breast cancer; results of management of axillary lymph node area in 3353 patients
46. Radiation-induced brachial plexopathy: Neurological follow-up in 161 recurrence-free breast cancer patients
47. Polychemotherapy for early breast cancer: An overview of the randomised trials
48. Adjuvant tamoxifen for early breast cancer: An overview of the randomised trials
49. The role of axillary dissection in operable breast cancer
50. Prediction of relapse of survival in patients with node-negative breast cancer by DNA flow cytometry
51. Indicators of prognosis in node-negative breast cancer
52. The DNA labelling index: A prognostic factor in node negative breast cancer
53. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
54. Expression of c-erb B-2 oncoprotein: A prognostic indicator in human breast cancer
55. Pathological findings from the National Surgical Adjuvant Breast and Bowel Project: Prognostic significance of c-erb B-2 protein overexpression in primary breast cancer
56. Epidermal-growth-factor receptor status as predictor of early recurrence or death from breast cancer
57. Cathepsin D and prognosis in breast cancer
58. The sentinel node and breast cancer
59. An approach for the treatment of penile carcinoma
60. Technical details of intraoperative lymphatic mapping for early stage melanoma
61. Gamma-probe-guided lymph node localisation in malignant melanoma
62. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe
63. Prognostic importance of occult axillary lymph node micrometastasis from breast cancers
64. The sentinel node in breast cancer: A multicenter validation study
65. Discontinuous or "skip" metastases in breast carcinoma: Analysis of 1228 axillary dissections
66. Patterns of axilliary lymph node metastasis in breast cancer
67. Sentinel lymph node detection and imaging
68. Sentinel-lymph node biopsy in breast cancer
69. The need to re-examine axillary lymph node dissection in invasive breast cancer